High Tolerance Plasticity Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : High Tolerance Plasticity

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: kodiak_bull who started this subject	6/6/2002 2:17:26 PM
From: Gator II	Read Replies (1) of 23153

CYTC went on sale this morning for all the wrong reasons imo. Its starting to recover now. CYTC dropped from mid-twenties to mid teens on news that it wanted to acquire Digene. Now that Digene's ace in the hole (licensing agreement from Pasteur Institute) has been flipped over to a potential competitor 15 to 18 mos from now, it would seem CYTC, the acquirer who was punished for buying Digene, should NOT have sold off this sharply if at all after Digene did. In addition, good news was released this a.m. that should favorably impact CYTC's sale of ThinPrep, its proprietary lead product that is rapidly becoming THE standard of care for women replacing the conventional pap smear test. We could see a rapid return from south of 12 to 15 or more on this one. I bought, ia anyone else following CYTC?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next